Omega Therapeutics's total assets for Q3 2024 were $152.73M, a decrease of -9.21% from the previous quarter. OMGA total liabilities were $141.18M for the fiscal quarter, a -0.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.